Solution Structure of Human SUMO-3 C47S and Its Binding Surface for Ubc9^,

Abstract

Small ubiquitin-related modifier SUMO-3 is a member of a growing family of ubiquitin-like proteins (Ubls). So far, four isoforms of SUMO have been identified in humans. It is generally known that SUMO modification regulates protein localization and activity. Previous structure and function studies have been mainly focused on SUMO-1. The sequence of SUMO-3 is 46% identical with that of SUMO-1; nevertheless, functional heterogeneity has been found between the two homologues. Here we report the solution structure of SUMO-3 C47S (residues 14-92) featuring the beta-beta-alpha-beta-beta-alpha-beta ubiquitin fold. Structural comparison shows that SUMO-3 C47S resembles ubiquitin more than SUMO-1. On the helix-sheet interface, a strong hydrophobic interaction contributes to formation of the globular and compact fold. A Gly-Gly motif at the C-terminal tail, extending away from the core structure, is accessible to enzymes and substrates. In vivo, SUMO modification proceeds via a multistep pathway, and Ubc9 plays an indispensable role as the SUMO conjugating enzyme (E2) in this process. To develop a better understanding of SUMO-3 conjugation, the Ubc9 binding surface on SUMO-3 C47S has been detected by chemical shift perturbation using NMR spectroscopy. The binding site mainly resides on the hydrophilic side of the beta-sheet. Negatively charged and hydrophobic residues of this region are highly or moderately conserved among SUMO family members. Notably, the negatively charged surface of SUMO-3 C47S is highly complementary in its electrostatic potentials and hydrophobicity to the positively charged surface of Ubc9. This work indicates dissimilarities between SUMO-3 and SUMO-1 in tertiary structure and provides insight into the specific interactions of SUMO-3 with its modifying enzyme.

Sumoylated Human Histone H4 Prevents Chromatin Compaction by Inhibiting Long-range Internucleosomal Interactions

“…This linkage strategy is known to be an effective mimic of the native isopeptide linkage between various target proteins and Ub or Smt3 (the yeast homolog of SUMO) (27,32). Furthermore, the SUMO-3 C47S mutation, which was required for selective disulfide formation at the SUMO C terminus, does not lead to observable structural changes (33). Our semisynthetic strategy readily yielded milligram quantities of homogeneous suH4 ss as seen by reversedphase high performance liquid chromatography (RP-HPLC) and ESI-MS (Fig.…”

Solution structure of Urm1 and its implications for the origin of protein modifiers

“…The dispersion of positive potential of the two proteins also is comparable. In contrast, the surfaces of other modifiers are usually divided roughly into ''acidic'' face and ''basic'' face as in ubiquitin (17)(18)(19). The positive potential region formed by Arg-6, Arg-54, Arg-42, and Arg-72 in ubiquitin is important for its activating and binding.…”

A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation

“…Previously, crystal structures of the SUMO-conjugating enzyme Ubc9 in complex with SUMO showed that noncovalent interaction between Ubc9 and SUMO also includes the surface covering the EIL (55)(56)(57)(58). However, in contrast to DPP9, Ubc9 does not differentiate between the SUMO paralogs.…”